Artal Group S.A.’s Kymera Therapeutics Inc Position
Does Artal Group S.A. own Kymera Therapeutics Inc (KYMR)? Not currently — the last reported position was 3.01M shares worth $90M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$90M
Q2 2024
Shares
3.01M
% of Portfolio
+2.29%
Quarters Held
16
position exited
Position History KYMR
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2024 | 3.01M | $90M | +2.29% |
| Q1 2024 | 3.03M | $122M | +3.10% |
| Q4 2023 | 2.53M | $64,433 | +2.14% |
| Q3 2023 | 1.81M | $25,094 | +1.08% |
| Q2 2023 | 1.81M | $41,505 | +1.29% |
| Q1 2023 | 1.81M | $53,492 | +3.18% |
| Q4 2022 | 2.00M | $49,920 | +2.79% |
| Q3 2022 | 1.50M | $33M | +1.39% |
| Q2 2022 | 1.00M | $20M | +1.05% |
| Q1 2022 | 1.00M | $42M | +1.77% |
| Q4 2021 | 1.00M | $63M | +1.72% |
| Q3 2021 | 400.0K | $23M | +0.53% |
| Q2 2021 | 250.0K | $12M | +0.25% |
| Q1 2021 | 250.0K | $10M | +0.17% |
| Q4 2020 | 250.0K | $16M | +0.33% |
| Q3 2020 | 250.0K | $8M | +0.20% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Artal Group S.A.’s full portfolio or all institutional holders of KYMR.